You just read:

Results of a Pivotal Phase 3 Efficacy and Safety Study for Butrans® (Buprenorphine) Transdermal System CIII Published in The Journal of Pain

News provided by

Purdue Pharma L.P.

Sep 23, 2011, 11:30 ET